Quantum Biopharma (QNTM) Assets Average (2024 - 2026)

Quantum Biopharma (QNTM) has 3 years of Assets Average data on file, last reported at $13.0 million in Q1 2026.

• For the quarter ending Q1 2026, Assets Average fell 18.46% year-over-year to $13.0 million; the trailing twelve-month figure through Mar 2026 stood at $13.0 million (down 18.46% YoY), and the FY2025 full-year result was $14.1 million, down 18.25% from the prior year.
• Assets Average improved to $13.0 million in Q1 2026, from $12.7 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $18.1 million in Q4 2024 to a low of $12.7 million in Q4 2025.
• A 3-year average of $15.2 million and a median of $15.1 million in 2025 frame the typical range for Assets Average.
• Peak annual rise in Assets Average reached 14.07% in 2025, while the deepest fall reached 29.97% in 2025.
• Tracing QNTM's Assets Average over 3 years: stood at $18.1 million in 2024, then fell by 29.97% to $12.7 million in 2025, then grew by 3.05% to $13.0 million in 2026.
• Business Quant data shows QNTM's Assets Average at $13.0 million in Q1 2026, $12.7 million in Q4 2025, and $14.7 million in Q3 2025.